Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Emerging indications for MARS dialysis.

G Schachschal1, S Morgera, S Küpferling

  • 1Charité (CCM), Medzinische Klinik mit Schwerpunkt für Gastroenterologie und Hepatology, Medzinische Fakultät der Humboldt-Universität zu Berlin, Germany. schachschal@web.de

Liver
|September 11, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The C/C_₁₃₉₁₀ and G/G_₂₂₀₁₈ Genotypes for Adult-type Hypolactasia are not Associated with Inflammatory Bowel Disease.

Scandinavian journal of gastroenterology·2017
Same author

Endoscopic ultrasound-guided drainage of abdominal fluid collections after pancreatic surgery: Efficacy and long-term follow-up.

Zeitschrift fur Gastroenterologie·2016
Same author

Impact of diet and nutraceutical supplementation on inflammation in elderly people. Results from the RISTOMED study, an open-label randomized control trial.

Clinical nutrition (Edinburgh, Scotland)·2015
Same author

A survey of treatment approaches of malignant ascites in Germany and Austria.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2014
Same author

[Begin of a new era in treating hepatitis C in Patients on the waiting list and after liver transplantation].

Zeitschrift fur Gastroenterologie·2014
Same author

Acute cellular rejection with isolated v-lesions is not associated with more favorable outcomes than vascular rejection with more tubulointerstitial inflammations.

Clinical transplantation·2014

Molecular Adsorbent Recirculating System (MARS) offers a treatment option for liver disease. This study explores its use in seven patients, discussing indications and initiation criteria for MARS dialysis.

Area of Science:

  • Hepatology
  • Nephrology
  • Critical Care Medicine

Background:

  • Liver disease management remains challenging, with limited options for acute or chronic liver failure.
  • Molecular Adsorbent Recirculating System (MARS) dialysis is an extracorporeal liver support system.
  • Optimal timing and patient selection for MARS therapy require further investigation.

Observation:

  • MARS dialysis was utilized in seven patients with various liver conditions, including chronic cholestatic liver disease and acute on chronic liver failure.
  • Patients received 2-12 MARS treatments between August 2000 and October 2001.
  • Diagnoses included alcoholic steatohepatitis, vanishing bile duct disease, metabolic liver disease, primary biliary cirrhosis, and drug-induced hepatitis.

Findings:

  • The study presents initial experiences with MARS dialysis in a small cohort.

Related Experiment Videos

  • Diverse liver pathologies were treated, indicating a broad potential application range for MARS.
  • The effectiveness and specific benefits of MARS across different etiologies are explored.

    • Implications:

    • This case series contributes to understanding the practical application of MARS dialysis.
    • Further research is needed to establish definitive guidelines for MARS initiation and patient selection.
    • MARS dialysis may represent a valuable therapeutic option for select patients with severe liver disease.